Diabetic Charcot Neurogenic Osteoarthropathy

Chapter
First Online:

Abstract

Diabetes mellitus (DM) is a group of metabolic diseases characterised by hyperglycaemia resulting from defects in insulin secretion, insulin action or both. Diabetes is one of the major threats to human health throughout the world. It decreases the quality of life and reduces life expectancy. The necessary long-term comprehensive healthcare provided to diabetic patients is also associated with a heavy socioeconomic burden.

Keywords

Autonomic Neuropathy Strontium Ranelate Plantar Pressure Valgus Deformity Skin Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Ahmadi ME, Morrison WB, Carrino JA, et al. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology. 2006;238(2):622–31.PubMedGoogle Scholar
  2. 2.
    Armstrong DG, Todd WF, Lavery LA, et al. The natural history of acute Charcot’s arthropathy in a diabetic foot speciality clinic. Diabet Med. 1997;14:357–63.PubMedGoogle Scholar
  3. 3.
    Armstrong DG, Lavery LA. Elevated peak plantar pressures in patient who have Charcot arthropathy. J Bone Joint Surg. 1998;80(3):365–9.PubMedGoogle Scholar
  4. 4.
    Balsells M, Viace J, Millan M, et al. Prevalence of osteomyelitis in non healing foot ulcers: usefulness of radiologic and scintigraphic findings. Diab Res Clin Pract. 1997;2:123–7.Google Scholar
  5. 5.
    Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. 1989;79:213–35.PubMedGoogle Scholar
  6. 6.
    Bartoš V, Pelikanová T, et al. Praktická diabetologie. Praha: Maxdorf; 2000. p. 455. [In Czech].Google Scholar
  7. 7.
    Bem R, Jirkovska A, Fejfarova V. Aktuality v diagnostice a lečbě Charcotovy osteoartropatie. Bulletin HPB chirurgie. 2006;4:53–9.Google Scholar
  8. 8.
    Bém R, Jirkovská A, Fejfarová V, et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. 2006;29(6):1392–4.PubMedGoogle Scholar
  9. 9.
    Berendt AR, Lipsky B. Is this bone infected or not? Differentiating neuroosteoarthropathy from osteomyelitis in the diabetic foot. Curr Diab Rep. 2004;4(6):424–9.PubMedGoogle Scholar
  10. 10.
    Boc SF, Brazzo K, Lavian D, Landino T. Acute Charcot foot changes versus osteomyelitis: does Tc-99 m HMPAO labeled leukocytes scan differentiate? J Am Podiatr Med Assoc. 2001;91(7):365–8.PubMedGoogle Scholar
  11. 11.
    Boulton AJM, Veves A, Young MJ. Etiopathogenesis and management of abnormal foot pressures. In: Levin ME, O’Neal LW, Bowker JH, editors. The diabetic foot. St. Louis: Mosby; 1993. p. 233–46.Google Scholar
  12. 12.
    Bradshaw TW. Aethiopatogenesis of the Charcot foot: an overview. Pract Diabetes Int. 1998;15(1):412–5.Google Scholar
  13. 13.
    Brooks AP. The neuropathic foot in diabetes. Part II. Charcot’s neuroarthropathy. Diabetic Med. 1986;3:116–8.PubMedGoogle Scholar
  14. 14.
    Brower AC, Allman RM. The neuropathic joint: a neurovascular bone disorder. Radiol Clin North Am. 1981;19:571–80.PubMedGoogle Scholar
  15. 15.
    Cavanagh PR, Young MJ, Adams JE, et al. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17(3):201–9.PubMedGoogle Scholar
  16. 16.
    Clouse ME, Gramm HF, Legg M, Flood T. Diabetic osteoarthropathy: clinical and roentgenological observation in 90 cases. Am J Roentgenol. 1974;121:22–3.Google Scholar
  17. 17.
    Cundy TF, Edmonds ME, Watkins PJ. Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med. 1985;2:461–4.PubMedGoogle Scholar
  18. 18.
    Downey MS. A closer look at bone stimulators for Charcot. Podiatry Today. 2006;19(12):52–8.Google Scholar
  19. 19.
    Dungl P. Ortopédie a traumatologie nohy. Praha: Avicenum; 1989. p. 282. [In Czech].Google Scholar
  20. 20.
    Eckardt A, Schoellner C, Decking J, et al. The impact of syme amputation in surgical treatment of patient with diabetic foot syndrome and Charcot-neuro-osteoarthropathy. Arch Orthop Traum Surg. 2004;124:145–50.Google Scholar
  21. 21.
    Eckhardt C. Grundlagen podologischer Behandlung beim Diabetikerfuss. In: OST – Sonderheft Diabetes. SOT – Societé Ortop.Traumatologique. 2005. p. 40–2.Google Scholar
  22. 22.
    Edelman SV, Kosofsky EM, Paul RA, Kozak GP. Neuro-arthropathy (Charcot joint) in diabetes mellitus following revascularisation surgery. Arch Intern Med. 1987;147:1504–8.PubMedGoogle Scholar
  23. 23.
    Edmonds ME, Clarke MB, Newton S, et al. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med (New Series). 1985;57:843–55.Google Scholar
  24. 24.
    Edmonds ME. The neuropathic foot in diabetes. Part I. Blood flow. Diabet Med. 1986;3:111–5.PubMedGoogle Scholar
  25. 25.
    Flynn MD, Tooke JE. Diabetic neuropathy and the microcirculation. Diabet Med. 1995;12:298–300.PubMedGoogle Scholar
  26. 26.
    Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg. 2004;43(2):87–92.PubMedGoogle Scholar
  27. 27.
    Foster DB, Basset RC. Neurogenic arthropathy (Charcot joint) associated with diabetic neuropathy: report of two cases. Archs Neurol Psychiat. 1947;57:173–85.Google Scholar
  28. 28.
    Fryberg RG. The diabetic Charcot foot. In: Kozak GP, Campbell DR, Frykberg RG, Habershaw GM, editors. Management of diabetic foot problems. Philadelphia: W. B. Saunders; 1995. p. 88–97.Google Scholar
  29. 29.
    Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev. 2000;16 Suppl 1:859–65.Google Scholar
  30. 30.
    Frykberg RG. Team approach toward lower extremity amputation prevention in diabetes. J Am Podiatr Med Assoc. 1997;87(7):305–12.PubMedGoogle Scholar
  31. 31.
    Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons (AMCFAS). J Foot Ankle Surg. 2000;39 Suppl 5:1–60.Google Scholar
  32. 32.
    Fryberg RG. Osteoarthropathy. Clin Podiatr Med Surg. 1987;4:351–3.Google Scholar
  33. 33.
    Gazis A, Pound N, Macfarlane R, et al. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diab Med. 2004;21:1243–6.Google Scholar
  34. 34.
    Giacalone VF, Krych SM, Harkless LB. The University of Texas Health Science Centre at San Antonio: experience with foot surgery in diabetics. J Foot Ankle Surg. 1994;33(6):590–7.PubMedGoogle Scholar
  35. 35.
    Giurato L, Uccioli L. The diabetic foot: Charcot joint and osteomyelitis. Nucl Med Commun. 2006;27(9):745–9.PubMedGoogle Scholar
  36. 36.
    Gostičev VK, Afanasjev AN, Chochlov AM. Surgical treatment of diabetic osteoarthropathy, complicated by pyogenic process in the feet (Rus). Chirurgia (Mosk). 1999;8:40–4.Google Scholar
  37. 37.
    Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14:527–31.PubMedGoogle Scholar
  38. 38.
    Graves M, Tarquinio TA. Diabetics neuroarthropathy (Charcot joints): the importance of recognizing chronic sensory deficits in the treatment of acute foot and ankle fractures in diabetic patients. Orthopedics. 2001;26(4):415–8.Google Scholar
  39. 39.
    Greitemann B. Der diabetische Fuss – Ursachen, Prophylaxie, konservative und operative Therapie. OrthopTechnik. 2000;3:172–84.Google Scholar
  40. 40.
    Greitemann B. Operative therapie und Amputationen am diabetischen Fuss. In: OST – Sonderheft Diabetes. SOT – Societé Ortop.Traumatologique. 2005. p. 30–6.Google Scholar
  41. 41.
    Griffiths JH. Diabetic osteopathy. Orthopedics. 1985;8:401–6.Google Scholar
  42. 42.
    Guillet C, Boirie Y. Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab. 2005;2:20–6.Google Scholar
  43. 43.
    Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg. 2004;86(B 1):378–83.Google Scholar
  44. 44.
    Herbst SA. External fixation of Charcot arthropathy. Foot Ankle Clin. 2004;9(3):595–609.PubMedGoogle Scholar
  45. 45.
    Hoffbauer LC, Heufelder AE. The roles of receptor activator nuclear factor–kB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone disease. J Clin Endocrinol Metab. 2000;85:2355–63.Google Scholar
  46. 46.
    Hoffbauer LC, Schoppet M. Clinical implications of the osteoprotegerin (RANKL) RANK system for bone and vascular diseases. JAMA. 2004;292:490–5.Google Scholar
  47. 47.
    Chantelau E, Onvlee GJ. Charcot foot in diabetes: farewell to the neurotrophic theory. Horm Metab Res. 2006;38(6):361–7.PubMedGoogle Scholar
  48. 48.
    Chappel R, Willems J, Martin JJ. Charcot joint in idiopathic sensorimotor neuropathy. Clin Rheumatol. 2000;19:153–5.PubMedGoogle Scholar
  49. 49.
    Charcot JM. Sur quelques rthropathies. Qui paraissent dependre d’une lesion. Du cerveau ou de la moelle epiniere. Arch Physiol Norm Pathol. 1868;1:161–78.Google Scholar
  50. 50.
    Jeffcoate WJ. Vascular calcification and osteolysis in diabetic neuropathy: is RANK-L the missing link? Diabetologia. 2004;47:1488–92.PubMedGoogle Scholar
  51. 51.
    Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366:2058–61.PubMedGoogle Scholar
  52. 52.
    Jeffcoate WEJ. Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy. Curr Diab Rep. 2005;5(6):430–5.PubMedGoogle Scholar
  53. 53.
    Jeffcoate WJ. Abnormalities of vasomotor regulation in the pathogenesis of the acute Charcot foot of diabetes mellitus. Low Extrem Wounds. 2005;4(3):133–7.Google Scholar
  54. 54.
    Jeffcoate W, Lima J, Norbrega L. The Charcot foot. Diabet Med. 2000;17(4):253–8.PubMedGoogle Scholar
  55. 55.
    Jirkovská A. Základní otázky léčby diabetické nohy. Vnitr Lek. 2002;48(6):542–8. [In Czech].PubMedGoogle Scholar
  56. 56.
    Jirkovská A, Hosová J, Wosková V. Diagnostika akutní a subakutní Charcotovy osteoartropatie u diabetiků. Prakt Lek. 1998;78(12):661–4. [In Czech].Google Scholar
  57. 57.
    Jordan WR. Neuritic manifestation in diabetes mellitus. Arch Int Med. 1936;57:307–66.Google Scholar
  58. 58.
    Judge MS. Infection and neuroarthropathy. The utility of C-reactive protein as a screening tool in the Charcot foot. J Am Podiatr Med Assoc. 2008;98(1):1–6.PubMedGoogle Scholar
  59. 59.
    Keidar Z, Militianu D, Melamed E, et al. The diabetic foot: initial experience with 18 F-FDG PET/CT. J Nucl Med. 2005;46(3):444–9.PubMedGoogle Scholar
  60. 60.
    Klenerman L. The Charcot joint in diabetes. Diabet Med. 1996;13:52–4.Google Scholar
  61. 61.
    Klenerman L. The foot and its disorders. Oxford: Blackwell Scientific Publications; 1976. p. 282.Google Scholar
  62. 62.
    Koller A, Fuhner J, Wetz HH. Radiological and clinical aspects of diabetic-neuropathic osteoarthropathy. Orthopade. 2004;3(9):972–82.Google Scholar
  63. 63.
    Krahulec B, Žúži M, Vozár J, et al. Diabetická polyneuropatia. Súčasné diagnostické a teapeutické možnosti. Bratislava: LUFEMA; 1999. p. 119. [In Slovak].Google Scholar
  64. 64.
    Larsen K, Fabrin J, Holstein PE. Incidence and management of ulcers in diabetic Charcot feet. J Wound Care. 2001;10(8):323–8.PubMedGoogle Scholar
  65. 65.
    Lavery LA, Armstrong DC, Walker SC. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot’s arthropathy. Diabet Med. 1997;14:46–9.PubMedGoogle Scholar
  66. 66.
    Lavery LA, Harkless LB. Treatment – based Classification system for assessment and care of diabetic feet. J Am Podiatr Med. 1996;86:311–6.Google Scholar
  67. 67.
    Lavery LA. Acute Charcot arthropathy of the foot and ankle. Phys Ther. 1998;78:74–80.PubMedGoogle Scholar
  68. 68.
    Lavery LA. Monitoring healing of acute Charcot’s arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317–21.PubMedGoogle Scholar
  69. 69.
    Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR imaging. Sem Musc Radiol. 2005;9(3):272–84.Google Scholar
  70. 70.
    Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17(5):571–80.PubMedGoogle Scholar
  71. 71.
    Leriche R. Sur quelques maladies osseouses et articulaire d’origine vaso motorice. Bull Mem Soc Nat Chir. 1927;53:1022–30.Google Scholar
  72. 72.
    Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006;117(7):212–38.Google Scholar
  73. 73.
    Marcus CD, Ladam-Marcus VJ, Leone J, et al. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics. 1996;16(6):1337–48.PubMedGoogle Scholar
  74. 74.
    Martin MM. Charcot joints in diabetes mellitus. Proc Roy Soc Med. 1952;45:503–6.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Martinka E. Syndróm diabetickej nohy a jeho moderná liečba. Int Med. 2005;5:547–55. [In Slovak].Google Scholar
  76. 76.
    Martinka E. Úskalia klasifikácie diabetes mellitus. Bratislava: LUFEMA; 1999. p. 170. [In Slovak].Google Scholar
  77. 77.
    Maurer AH, Millmond SH, Knight LC, et al. Infection in diabetic osteoarthropathy: use of indium-labeled leukocytes for diagnosis. Radiology. 1986;161:221–5.PubMedGoogle Scholar
  78. 78.
    Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am. 2004;40(5):1171–92.Google Scholar
  79. 79.
    Osterhouse MD, Kettner NW. Neuropathic osteoarthropathy in the diabetic foot. Case report. J Manipulative Physiol Ther. 2002;26(6):416–22.Google Scholar
  80. 80.
    Pakarinen TK, Laine HJ, Honkonen SE, et al. Charcot arthropathy of the diabetic foot. Current concepts and re view of 36 cases. Scand J Surg. 2002;91(2):195–201.PubMedGoogle Scholar
  81. 81.
    Palmaj J, Palmajová R. Chirurgická liečba diabetickej Charcotovej neuroosteoartropatie a špecifiká predoperačnej a pooperačnej starostlivosti. Rheumatologia. 2007;21(1):7–14. [In Slovak].Google Scholar
  82. 82.
    Palmajová R, Palmaj J. Diabetická Charcotova neurogénna osteoarthropatia – závažna mutilujúca komplikácia diabetes mellitus. Lék Listy. 2001;14:5–16. [In Slovak].Google Scholar
  83. 83.
    Palmajová R, Palmaj J. Rádiologické zmeny pri diabetickej neurogénnej Charcotovej osteoartropatii. Slov Radiologia. 2002;2:74–8. [In Slovak].Google Scholar
  84. 84.
    Palmajová R. Diabetická Charcotova neurogénna osteoartropatia. In: Rovenský J, et al., editors. Reumatológia v teórii a praxi VI. Martin: Osveta; 2004. p. 529–45. [In Slovak].Google Scholar
  85. 85.
    Perušičová J, et al. Diabetes mellitus 2. typu. Praha: Galen; 1996. p. 120. [In Czech].Google Scholar
  86. 86.
    Petrova NL, Foster AVM, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between type 1 and type 2 diabetes. Diabet Med. 2005;22:756–61.PubMedGoogle Scholar
  87. 87.
    Piaggesi A, Rizzo L, Golia F, et al. Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. Diabetes Res Clin Pract. 2002;58:1–9.PubMedGoogle Scholar
  88. 88.
    Philip T. Diabetes mellitus – změny na pohybovem ustroji. Reumatologie. 1999;13(2):73–80.Google Scholar
  89. 89.
    Pinzur MS, Shields N, Trepman E, et al. Current practice patterns in the treatment of Charcot foot. Foot Ankle Int. 2000;21(11):916–20.PubMedGoogle Scholar
  90. 90.
    Pinzur MS. Charcot’s foot. Foot Ankle Clin. 2000;5(4):897–912.PubMedGoogle Scholar
  91. 91.
    Pinzur MS, Noonan T. Ankle arthrodesis with a retrograde femoral nail for Charcot ankle arthropathy. Foot Ankle Int. 2005;26(7):545–59.PubMedGoogle Scholar
  92. 92.
    Pinzur MS. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004;25(8):545–9.PubMedGoogle Scholar
  93. 93.
    Plášil R, Martinka E. Terapia a prevencia syndrómu diabetickej nohy. Bratislava: SAP; 2007. p. 53–7. [In Slovak].Google Scholar
  94. 94.
    Ponťuch P, Strmeň P, Krahulec B, Vozár J. Diabetická nefropatia, retinopatia, neuropatia. Martin: Osveta; 1993. p. 150. [In Slovak].Google Scholar
  95. 95.
    Rumenapf G, Lang W. Diabetische neuropatische Osteoaertropatie (Charcot Fuss). Zentralbl Chir. 2003;9:734–9.Google Scholar
  96. 96.
    Rušavy Z, et al. Diabetická noha. Diagnostika a terapie v praxi. Praha: Galen; 1998. p. 178. [In Czech].Google Scholar
  97. 97.
    Salzmann CL, Hagy ML, Zimmerman B, et al. How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy in feet. Clin Ortho Relat Res. 2005;435:185–90.Google Scholar
  98. 98.
    Sammarco GJ, Conti SF. Surgical treatment of neuroarthropathic foot deformity. Foot Ankle Int. 1998;2:102–9.Google Scholar
  99. 99.
    Sanders LJ. The Charcot foot: historical perspective 1827–2003. Diabetes Metab Res Rev. 2004;20 Suppl 1:4–8.Google Scholar
  100. 100.
    Sanders LJ, Mrdjenovich D. Anatomical patterns of bone and joint destruction in neuropathic diabetics (abstract). Diabetes. 1991;40 Suppl 1:529A.Google Scholar
  101. 101.
    Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: the Charcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991. p. 297–338.Google Scholar
  102. 102.
    Shah MK, Hugghins SY. Charcot’s joint: an overlooked diagnosis. J La State Med Soc. 2002;154(5):246–50.PubMedGoogle Scholar
  103. 103.
    Shaw JE, Van Schie CHM, Carrington AL, et al. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabet Care. 1998;21(11):1959–60.Google Scholar
  104. 104.
    Schon LC, Easley ME, Weinfeld SB. Charcot Neuroarthropathy of the foot and ankle. Clin Orthop. 1998;349:116–31.Google Scholar
  105. 105.
    Schon LC, Marks RM. The management of neuroarthropathic fracture dislocations in the diabetic patient. Orthop Clin North Am. 1995;26:375–92.PubMedGoogle Scholar
  106. 106.
    Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am. 2004;42(1):61–71.PubMedGoogle Scholar
  107. 107.
    Selby PL, Young MJ, Boulton AJM. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11:28–31.PubMedGoogle Scholar
  108. 108.
    Sella EJ, Grosser DM. Imaging modalities of diabetic foot. Clin Podiatr Med Surg. 2003;20(4):729–40.PubMedGoogle Scholar
  109. 109.
    Serra F, Mancini L, Ghirlanda G, Ruotolo V. Charcot’s foot. Rays. 1997;22(4):524–34.PubMedGoogle Scholar
  110. 110.
    Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29(12):736–46.PubMedGoogle Scholar
  111. 111.
    Sinha S, Frykberg RG, Kozak GP. Neuroarthropathy in the diabetes foot. In: Kozak GP, editor. Clinical diabetes mellitus. Philadelphia: W. B. Saunders; 1993. p. 415–25.Google Scholar
  112. 112.
    Sinha S, Munichoadappa C, Kozak GP. Neuroarthropathy (Charcot joints) in diabetes mellitus: a clinical study. Diabet Med. 1994;12:33–5.Google Scholar
  113. 113.
    Spraul M. Klinik, Diagnose und konservative Therapie des diabetischen Fusssyndroms. In: OST – Sonderheft Diabetes. SOT – Societé Ortop.Traumatologique. 2005. p. 14–22.Google Scholar
  114. 114.
    Stone NC, Daniels TR. Midfoot and hindfoot arthrodesis in diabetic Charcot arthropathy. Can J Surg. 2000;43(6):449–55.PubMedPubMedCentralGoogle Scholar
  115. 115.
    Thompson Jr RC, Clohisy DR. Deformity Following fracture in diabetic neuropathic osteoarthropathy: operative management of adults who have type-1 diabetes. J Bone Joint Surg Am. 1993;75A:1765–73.Google Scholar
  116. 116.
    Tomas MB, Patel M, Marvin SE, Palestro CJ. The diabetic foot. Br J Radiol. 2000;73(868):443–50.PubMedGoogle Scholar
  117. 117.
    Van Baal JG, Manning HA, Hissink RJ. Die Casting-Technik bei der Behandlung von neuropathischen diabetischen Fussulzera. Orthop Technik. 2001;3:170–5.Google Scholar
  118. 118.
    Vaško G, Jenčikova Ľ. Diabeticka osteoartropatia. Slov Lek. 1997;2:26–7.Google Scholar
  119. 119.
    Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47:457–63.PubMedGoogle Scholar
  120. 120.
    Vohradníková O, Perušičová J. Kožní projevy při diabetes mellitus. Praha: Maxdorf; 1996. p. 135–8. [In Czech].Google Scholar
  121. 121.
    Vozár J, Kreze A, Klimeš I. Diabetes mellitus. Bratislava: SAP; 1998. p. 278. [In Slovak].Google Scholar
  122. 122.
    Wagner W. The diabetic foot and amputations of the foot. In: Mann EA, editor. Surgery of the foot. St. Louis: Mosby; 1986. p. 808–12.Google Scholar
  123. 123.
    Wagner A, Fuhrmann R, Roth A. Charcot foot treated by correction and arthrodesis of the hindfoot. Oper Orthop Traumatol. 2005;17(4–5):554–62.PubMedGoogle Scholar
  124. 124.
    Ward JD. The diabetic leg. Diabetologia. 1982;22:141–7.PubMedGoogle Scholar
  125. 125.
    Wetz H-H. Die ortopadisch – chirurgische Behandlung des diabetischen Fusssyndroms. In: OST – Sonderheft Diabetes. SOT – Societé Ortop.Traumatologique. 2005. p. 23–9.Google Scholar
  126. 126.
    Williamson JR, Tilton RG, Chang K, Kilo C. Basement membrane abnormalities in diabetes mellitus relationship to clinical microangiopathy. Diabetologia. 1981;22:339–70.Google Scholar
  127. 127.
    Young MJ, Marshall A, Adams JE, et al. Osteopenias neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18:34–8.PubMedGoogle Scholar
  128. 128.
    Yu JS. Diabetic foot and neuroarthropathy: magnetic resonance imaging evaluation. Top Magn Reson Imaging. 1998;9(5):295–310.PubMedGoogle Scholar
  129. 129.
    Zwipp H, Rammelt S, Dahlen C, Reichmann H. Das Charcot – Gelenk. Orthopade. 1999;28:550–8.PubMedGoogle Scholar
  130. 130.
    Kadlec M. Diabetická neuropatie – neřešitelný problém. Hradec Králové, Worwag Pharma, 2000. p. 21. (In Czech).Google Scholar
  131. 131.
    International Consensus on the Diabetic Foot by the International Working Group on the Diabetic Foot. May 1999.Google Scholar
  132. 132.
    Syndrom diabetické nohy. Mezinárodní konsenzus vypracovaný Mezinarodní pracovní skupinou pro syndrom diabeticke nohy. Praha: Galen; 2000. p. 101. [In Czech].Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Centre for Diabetology and MetabolismBratislavaSlovakia
  2. 2.Specialized Hospital for Orthopeadic ProstheticsBratislavaSlovakia

Personalised recommendations